TEVA PHARMACEUTICAL INDUSTRIES LIMITED Proceeds from Long-Term Debt Issued
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) reported Proceeds from Long-Term Debt Issued of $4.43 billion for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2018-11-01
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from issuance of long-term debt for the quarter ending 2018-09-30 was -$1.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from issuance of long-term debt for the quarter ending 2018-06-30 was -$5.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from issuance of long-term debt for the quarter ending 2018-03-31 was $4.44B.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED proceeds from issuance of long-term debt for the quarter ending 2017-09-30 was -$14.00M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2018-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$6.00M derived: sum of 2 quarters · filed 2018-11-01 | $4.43B 10-Q · filed 2018-11-01 | |
| 2018-06-30 | -$5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $4.43B 10-Q · filed 2018-08-02 | ||
| 2018-03-31 | $4.44B 10-Q · filed 2018-05-03 | |||
| 2017-09-30 | -$14.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $507.00M 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | $521.00M 10-Q · filed 2018-08-02 | |||
| 2010-09-30 | $1.00M derived: 6-K 9 month − 6-K 6 month · filed 2010-11-02 | $43.00M derived: sum of 2 quarters · filed 2010-11-02 | $44.00M 6-K · filed 2010-11-02 | $184.00M derived: sum of 4 quarters · filed 2010-11-02 |
| 2010-06-30 | $42.00M derived: 6-K 6 month − 6-K 3 month · filed 2010-07-27 | $43.00M 6-K · filed 2010-07-27 | $183.00M derived: sum of 3 quarters · filed 2010-07-27 | $211.00M derived: sum of 4 quarters · filed 2010-11-02 |
| 2010-03-31 | $1.00M 6-K · filed 2010-05-04 | $141.00M derived: sum of 2 quarters · filed 2010-05-04 | $169.00M derived: sum of 3 quarters · filed 2010-11-02 | $178.00M derived: sum of 4 quarters · filed 2010-11-02 |
| 2009-12-31 | $140.00M derived: 20-F 12 month − 6-K 9 month · filed 2010-02-22 | $168.00M derived: sum of 2 quarters · filed 2010-11-02 | $177.00M derived: sum of 3 quarters · filed 2010-11-02 | $445.00M 20-F · filed 2010-02-22 |
| 2009-09-30 | $28.00M derived: 6-K 9 month − 6-K 6 month · filed 2010-11-02 | $37.00M derived: sum of 2 quarters · filed 2010-11-02 | $305.00M 6-K · filed 2010-11-02 | $340.00M derived: sum of 4 quarters · filed 2010-11-02 |
| 2009-06-30 | $9.00M derived: 6-K 6 month − 6-K 3 month · filed 2010-07-27 | $277.00M 6-K · filed 2010-07-27 | $312.00M derived: sum of 3 quarters · filed 2010-07-27 | $313.00M derived: sum of 4 quarters · filed 2010-07-27 |
| 2009-03-31 | $268.00M 6-K · filed 2010-05-04 | $303.00M derived: sum of 2 quarters · filed 2010-05-04 | $304.00M derived: sum of 3 quarters · filed 2010-05-04 | $305.00M derived: sum of 4 quarters · filed 2010-05-04 |
| 2008-12-31 | $35.00M derived: 20-F 12 month − 6-K 9 month · filed 2010-02-22 | $36.00M derived: sum of 2 quarters · filed 2010-02-22 | $37.00M derived: sum of 3 quarters · filed 2010-02-22 | $39.00M 20-F · filed 2010-02-22 |
| 2008-09-30 | $1.00M derived: 6-K 9 month − 6-K 6 month · filed 2009-11-03 | $2.00M derived: sum of 2 quarters · filed 2009-11-03 | $4.00M 6-K · filed 2009-11-03 | |
| 2008-06-30 | $1.00M derived: 6-K 6 month − 6-K 3 month · filed 2009-07-29 | $3.00M 6-K · filed 2009-07-29 | ||
| 2008-03-31 | $2.00M 6-K · filed 2009-05-07 | |||
| 2007-12-31 | $37.00M 20-F · filed 2010-02-22 |